Skip to main content
Top
Published in: Endocrine 2/2016

01-02-2016 | Editorial

Vitamin D status as a synthetic biomarker of health status

Author: Philippe Autier

Published in: Endocrine | Issue 2/2016

Login to get access

Excerpt

A considerable number of ecological, cross-sectional and of observational studies have documented the association between low vitamin D status (assessed by the measurement of serum 25-hydroxyvitamin D concentration [25(OH)D]) and a greater risk of being diagnosed with a myriad of diseases, including minor ailments and rare conditions [1]. Many have concluded from these non-interventional studies that low vitamin D status could be a cause of ill health, and that maintaining a high 25(OH)D could represent an easy way to prevent diseases and increase life expectancy. But the numerous randomised trials done to date on vitamin D supplementation did not confirm the health benefits of increased 25(OH)D, even when high doses of supplementation (i.e. ≥50 µg per day) were used in subjects with low vitamin D status before randomisation [2]. Large-size randomised trials on vitamin D supplementation are on-going [3, 4]. While awaiting for results of these trials, perhaps the cautious view is to consider that low 25(OH)D is a consequence and not a cause, of debilitated health. …
Literature
2.
go back to reference P. Autier, M. Boniol, C. Pizot, P. Mullie, Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2(1), 76–89 (2014)CrossRefPubMed P. Autier, M. Boniol, C. Pizot, P. Mullie, Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2(1), 76–89 (2014)CrossRefPubMed
3.
go back to reference J.E. Manson, S.S. Bassuk, Vitamin D research and clinical practice: at a crossroads. JAMA 313(13), 1311–1312 (2015)CrossRefPubMed J.E. Manson, S.S. Bassuk, Vitamin D research and clinical practice: at a crossroads. JAMA 313(13), 1311–1312 (2015)CrossRefPubMed
4.
go back to reference R. Scragg, D. Waayer, A.W. Stewart, C.M. Lawes, L. Toop, J. Murphy, K.T. Khaw, C.A. Camargo Jr., The Vitamin D Assessment (ViDA) Study: design of a randomized controlled trial of vitamin D supplementation for the prevention of cardiovascular disease, acute respiratory infection, falls and non-vertebral fractures. J. Steroid Biochem. Mol. Biol. (2015). doi:10.1016/j.jsbmb.2015.09.010 R. Scragg, D. Waayer, A.W. Stewart, C.M. Lawes, L. Toop, J. Murphy, K.T. Khaw, C.A. Camargo Jr., The Vitamin D Assessment (ViDA) Study: design of a randomized controlled trial of vitamin D supplementation for the prevention of cardiovascular disease, acute respiratory infection, falls and non-vertebral fractures. J. Steroid Biochem. Mol. Biol. (2015). doi:10.​1016/​j.​jsbmb.​2015.​09.​010
5.
go back to reference T. Skaaby, L.L.N. Husemoen, B.H. Thuesen, C. Pisinger, A. Hannemann, T. Jørgensen, A. Linneberg, Longitudinal associations between lifestyle and vitamin D: a general population study with repeated vitamin D measurements. Endocrine (2015). doi:10.1007/s12020-015-0641-7 T. Skaaby, L.L.N. Husemoen, B.H. Thuesen, C. Pisinger, A. Hannemann, T. Jørgensen, A. Linneberg, Longitudinal associations between lifestyle and vitamin D: a general population study with repeated vitamin D measurements. Endocrine (2015). doi:10.​1007/​s12020-015-0641-7
6.
go back to reference G. McNeill, J. Vyvyan, H. Peace, L. McKie, G. Seymour, J. Hendry et al., Predictors of micronutrient status in men and women over 75 years old living in the community. Br. J. Nutr. 88(5), 555–561 (2002)CrossRefPubMed G. McNeill, J. Vyvyan, H. Peace, L. McKie, G. Seymour, J. Hendry et al., Predictors of micronutrient status in men and women over 75 years old living in the community. Br. J. Nutr. 88(5), 555–561 (2002)CrossRefPubMed
7.
go back to reference M.J. Bolland, A. Grey, G.D. Gamble, I.R. Reid, The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2(4), 307–320 (2014)CrossRefPubMed M.J. Bolland, A. Grey, G.D. Gamble, I.R. Reid, The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2(4), 307–320 (2014)CrossRefPubMed
8.
go back to reference M.J. Bolland, A. Grey, G.D. Gamble, I.R. Reid, Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2(7), 573–580 (2014)CrossRefPubMed M.J. Bolland, A. Grey, G.D. Gamble, I.R. Reid, Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2(7), 573–580 (2014)CrossRefPubMed
Metadata
Title
Vitamin D status as a synthetic biomarker of health status
Author
Philippe Autier
Publication date
01-02-2016
Publisher
Springer US
Published in
Endocrine / Issue 2/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0837-x

Other articles of this Issue 2/2016

Endocrine 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine